Biotech catalyst calendar
Track PDUFA dates, FDA decisions, clinical readouts, and company news from official sources—without jumping between calendars, filings, and feeds.
Coverage
1000+ U.S.-listed biotech and pharma stocks
Sources
Press releases, SEC filings, FDA updates, trial results
Delivery
Critical alerts delivered within 5 minutes
Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies of NTX-253 for Schizophrenia
argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
FDA calendar
TECENTRIQ (atezolizumab) and TECENTRIQ HYBREZA (atezolizumab and hyaluronidase-tqjs) plus chemotherapy
Adjuvant treatment of stage III dMMR/MSI-H colon cancer · Patients with resected stage III deficient DNA mismatch repair or microsatellite instability-high colon cancer
Ifinatamab deruxtecan (I-DXd)
Previously treated extensive-stage small cell lung cancer · Adults with extensive-stage small cell lung cancer whose disease progressed on or after platinum-based chemotherapy
ENSPRYNG (satralizumab)
Moderate-to-severe thyroid eye disease · Adults with moderate-to-severe active thyroid eye disease
MR-141 (phentolamine ophthalmic solution 0.75%)
Presbyopia · Adults with presbyopia
Bepirovirsen
Chronic hepatitis B · Adults with chronic hepatitis B
Company catalysts
Read each company’s future catalyst outlook directly in the card, then open its profile for the full company context.
TENX
Tenax Therapeutics, Inc.
BBLG
Bone Biologics
INBS
Intelligent Bio Solutions
REVB
Revelation Biosciences
FEMY
FEMASYS
GOVX
GeoVax Labs
What it does
BioPharmSignal reduces the work of monitoring biotech catalysts by keeping the highest-signal updates in one calendar-first product.
Full Coverage
Official Sources
Real-time News
Calendar alerts
BioPharmSignal keeps delivery immediate and lightweight, so you do not need to monitor inboxes or refresh multiple tabs to catch important biotech catalysts.
Critical biotech headlines arrive directly in the browser as they happen.
When the page is added to a phone home screen, the same push flow can surface on mobile too.
No inbox checking, no tab hunting, and no extra workflow to catch important catalysts.
Message notification
biopharmsignal.com
You have a new biotech catalyst alert. Please review promptly.
Saved app
BioPharmSignal
Investor Fit
BioPharmSignal is built for users who already follow the events that drive biotech prices and want a cleaner way to stay current.
1000+
stocks covered
5 min
delivery target
24/7
monitoring
A biotech catalyst calendar is a way to track upcoming FDA dates, clinical readouts, and company events that can change how a biotech stock trades.
An FDA calendar is a dated view of upcoming regulatory milestones such as PDUFA dates, advisory committee meetings, and other decision points tied to biotech companies.
A PDUFA date is the target date by which the FDA aims to decide on a drug application, making it one of the most important biotech catalyst dates to watch.
A biotech watchlist is a saved set of companies, drugs, or keywords you want to keep visible so you can follow the same names and catalysts over time.
Biotech alerts work by monitoring the sources you care about and surfacing new catalyst-style headlines as they arrive, so you can react without manually checking many pages.
BioPharmSignal is designed to surface critical biotech headlines within minutes whenever possible, especially for company press releases, FDA updates, SEC filings, and clinical trial news.
No. Coverage is automatic across the U.S.-listed biotech and pharma universe, so you can start with the livefeed and then narrow the view using saved tickers and keywords when needed.
BioPharmSignal focuses on high-signal official and near-official sources, including company press releases, SEC filings, FDA updates, and clinical trial headlines that can move biotech stocks.
The product is built for biotech investors, operators, and teams that need fast awareness of catalyst-driven updates without monitoring dozens of investor relations pages manually.
Yes. BioPharmSignal supports saved tickers and keywords so you can focus on a small watchlist, a handful of catalysts, or a broader theme such as obesity, oncology, or gene editing.
Typical events include FDA decisions, PDUFA-related headlines, clinical readouts, partnership announcements, financing news, SEC filings, launch updates, and other catalyst-style company news.
